Search clinical trials for: BRCA1 mutation carrier
Total 3731 results
-
University of California, San FranciscoAmerican Cancer Society, Inc.CompletedBRCA1 Gene Mutation | BRCA2 Gene MutationUnited States
-
Ohio State University Comprehensive Cancer CenterRecruitingBRCA1 Gene Mutation | BRCA2 Gene MutationUnited States
-
European Institute of OncologyCompletedBRCA1 Mutation | BRCA2 Mutation | Psychosocial FactorsItaly
-
OncoNano Medicine, Inc.RecruitingLymphoma, Non-Hodgkin | Follicular Lymphoma | Carcinoma in Situ | Mantle Cell Lymphoma | Metastatic Cancer | Bladder Cancer | Skin Cancer | Triple Negative Breast Cancer | Cervix Cancer | Diffuse Large B Cell Lymphoma | Head and Neck Squamous Cell Carcinoma | Tumor, Solid | Tumor Recurrence | Uveal Melanoma, RecurrentUnited States
-
University Health Network, TorontoWomen's College Hospital; Jewish General Hospital; IWK Health Centre; British Columbia... and other collaboratorsRecruiting
-
AstraZenecaCompletedAdvanced Solid TumorsUnited States, Spain
-
National Human Genome Research Institute (NHGRI)CompletedBreast CancerUnited States
-
University Health Network, TorontoHamilton Health Sciences Corporation; Mount Sinai Hospital, CanadaCompleted
-
PfizerMedivation, Inc.CompletedBreast Neoplasms | BRCA 1 Gene Mutation | BRCA 2 Gene MutationKorea, Republic of, United States, Australia, Spain, Belgium, France, Ireland, Taiwan, Poland, Germany, Israel, Brazil, United Kingdom, Italy, Russian Federation, Ukraine
-
PfizerMedivation, Inc.; Myriad Genetic Laboratories, Inc.TerminatedBreast Neoplasms | BRCA 1 Gene Mutation | BRCA 2 Gene MutationUnited States, Spain, United Kingdom, Germany, France
-
IDEAYA BiosciencesRecruitingBreast Cancer | Ovarian Cancer | Prostate Cancer | Pancreas Cancer | Advanced or Metastatic Solid TumorsUnited States
-
Institut CurieCompletedWomen With BRCA1 Germline Deleterious MutationFrance
-
University Hospital, GhentFox Chase Cancer Center; Ziekenhuis Oost-LimburgCompletedBRCA1 Mutation | BRCA2 Mutation | hCGBelgium
-
nVision MedicalCompletedBRCA1 Mutation | BRCA2 Mutation | Atypia Suspicious for MalignancyUnited States
-
Fox Chase Cancer CenterNational Cancer Institute (NCI)TerminatedBreast Cancer | BRCA1 MutationUnited States, Austria
-
National Human Genome Research Institute (NHGRI)CompletedBreast CancerUnited States
-
Sierra Oncology LLC - a GSK companyCompletedAdvanced Solid Tumors or Non-Hodgkin's Lymphoma (NHL)United Kingdom
-
Priyanka SharmaBristol-Myers Squibb; Celgene CorporationActive, not recruitingBreast Cancer | Triple-Negative Breast CancerUnited States
-
Georgetown UniversityNational Cancer Institute (NCI); National Human Genome Research Institute (NHGRI)CompletedBreast Cancer | Ovarian CancerUnited States
-
University of MichiganNational Cancer Institute (NCI)CompletedOvarian Cancer Risk | Risk-reducing Surgery | Fallopian Tube Fimbriae | Ovarian Cortical Inclusion CystsUnited States, Canada
-
National Human Genome Research Institute (NHGRI)TerminatedBreast Cancer | Ovarian Neoplasm | Cancer GeneticsUnited States
-
Spanish Lung Cancer GroupTerminatedCarcinoma, Non Small Cell LungSpain
-
Tongji UniversityUnknownNon-small Cell Lung CancerChina
-
Beth Israel Deaconess Medical CenterWashington University School of Medicine; Rush University Medical Center; Wake... and other collaboratorsRecruitingPancreatic Cancer, AdultUnited States
-
Calithera Biosciences, IncTerminatedClear Cell Renal Cell Carcinoma | Colorectal Cancer | Solid Tumor | CRC | TNBC - Triple-Negative Breast Cancer | ccRCC | RCCUnited States
-
University of WashingtonNational Cancer Institute (NCI)Active, not recruitingMetastatic Prostate Carcinoma | Stage IV Prostate Cancer AJCC v8 | Stage IVB Prostate Cancer AJCC v8United States
-
Mayo ClinicEnrolling by invitation
-
Sierra Oncology LLC - a GSK companyCompletedAdvanced Solid TumorsSpain, United Kingdom
-
University of WashingtonCompletedOvarian CancerUnited States
-
Wales Cancer Trials UnitPierre Fabre LaboratoriesCompleted
-
Centro Nacional de Investigaciones Oncologicas...Fundación Pública Andaluza para la Investigación de Málaga en Biomedicina... and other collaboratorsCompletedProstate Cancer
-
Eunice Kennedy Shriver National Institute of Child...Completed
-
Spanish Lung Cancer GroupCompletedNon-small-cell Lung CancerSpain
-
Fondazione IRCCS Istituto Nazionale dei Tumori,...Istituto Oncologico di BariCompletedBreast Cancer | BRCA1 Mutation | BRCA2 Mutation | Dietary ModificationItaly
-
Rabin Medical CenterCompletedBRCA1 Gene Mutation | BRCA2 Gene MutationIsrael
-
UNICANCERCompletedLetrozole in Preventing Breast Cancer in Postmenopausal Women With a BRCA1 or BRCA2 Mutation (LIBER)Breast Cancer | Hereditary Breast/Ovarian Cancer (brca1, brca2) | brca1 Mutation Carrier | brca2 Mutation CarrierFrance
-
Indiana UniversityBreast Cancer Research FoundationWithdrawnHigh-grade Serous Ovarian Cancer | BRCA1 Mutation | TNBC - Triple-Negative Breast CancerUnited States
-
The Affiliated Nanjing Drum Tower Hospital of Nanjing...Unknown
-
National Cancer Institute (NCI)Recruiting
-
H. Lee Moffitt Cancer Center and Research InstituteNational Institutes of Health (NIH)Completed
-
Okayama UniversityMerck Sharp & Dohme LLCRecruitingBreast Cancer | Breast Neoplasms | Triple Negative Breast Cancer | Triple Negative Breast Neoplasms | BRCA1 Mutation | BRCA2 Mutation | BRCA Mutation | BRCA-Associated Breast CarcinomaJapan
-
Dana-Farber Cancer InstituteWithdrawnOvarian Cancer | Fallopian Tube Cancer | Peritoneal CancerUnited States
-
University Hospital, MontpellierCompleted
-
University of California, San FranciscoGlaxoSmithKlineRecruitingMetastatic Solid Tumor | BRCA1 Mutation | BRCA2 Mutation | PALB2 Gene Mutation | ATM Gene MutationUnited States
-
Hanyang University Seoul HospitalKorean Surgical Society; Korea Robot-Endoscopy Minimal Access Breast Surgery...CompletedBRCA1/2 Mutation | Breast-conserving SurgeryKorea, Republic of
-
University Health Network, TorontoTerminated
-
AstraZenecaCompleted
-
Technical University of MunichCompletedHereditary Breast and Ovarian CancerGermany
-
Southwest Oncology GroupNational Cancer Institute (NCI)CompletedBreast Cancer | brca1 Mutation Carrier | brca2 Mutation CarrierUnited States
-
NYU Langone HealthWithdrawnBreast Cancer | BRCA1 Mutation | BRCA2 MutationUnited States